PMID- 19859680 OWN - NLM STAT- MEDLINE DCOM- 20100430 LR - 20211020 IS - 1433-044X (Electronic) IS - 0177-5537 (Linking) VI - 112 IP - 12 DP - 2009 Dec TI - [Thrombosis prophylaxis in trauma surgery units in Germany: a survey]. PG - 1029-33 LID - 10.1007/s00113-008-1557-y [doi] AB - BACKGROUND: A questionnaire study was conducted to ask trauma surgery centers about thrombosis prophylaxis methods and strategies for the diagnosis and therapy of heparin-induced thrombocytopenia (HIT). METHODS: Questionnaires were sent by post to German hospitals with trauma surgery units inquiring about the use of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH), the duration of medication, and the HIT diagnosis. Questionnaires were evaluated descriptively. RESULTS: 314 of 685 questionnaires sent out were evaluable (46%): half were from general hospitals, 96 (31%) from specialized hospitals, and 53 (17%) from tertiary care hospitals (others: 8). In more than 90%, only LMWH was used. The mean duration of pharmacological thrombosis prophylaxis was 16.6+/-10.4 days (inpatient/outpatient). Only 10% adhered to the recommended platelet count controls every 2 days (days 5-14) for early detection of HIT. CONCLUSIONS: While pharmacological thrombosis prophylaxis following trauma surgery seems to be generally performed according to guidelines, diagnosis and treatment of HIT need to be systematized. FAU - Hinz, P AU - Hinz P AD - Unfall- und Wiederherstellungschirurgie, Klinikum der Ernst-Moritz-Arndt Universitat, Greifswald, Deutschland. phinz@uni-greifswald.de FAU - Lubenow, N AU - Lubenow N FAU - Wessel, A AU - Wessel A FAU - Greinacher, A AU - Greinacher A FAU - Ekkernkamp, A AU - Ekkernkamp A LA - ger PT - English Abstract PT - Journal Article TT - Thromboseprophylaxe in unfallchirurgischen Abteilungen in Deutschland : Eine Umfrage. PL - Germany TA - Unfallchirurg JT - Der Unfallchirurg JID - 8502736 RN - 0 (Heparin, Low-Molecular-Weight) RN - 9005-49-6 (Heparin) SB - IM MH - Germany MH - Health Surveys MH - Heparin/adverse effects/*therapeutic use MH - Heparin, Low-Molecular-Weight/adverse effects/*therapeutic use MH - Humans MH - Platelet Count MH - Pulmonary Embolism/blood/*prevention & control MH - Surveys and Questionnaires MH - Thrombocytopenia/chemically induced MH - Venous Thrombosis/blood/*prevention & control MH - Wounds and Injuries/blood/*surgery EDAT- 2009/10/28 06:00 MHDA- 2010/05/01 06:00 CRDT- 2009/10/28 06:00 PHST- 2009/10/28 06:00 [entrez] PHST- 2009/10/28 06:00 [pubmed] PHST- 2010/05/01 06:00 [medline] AID - 10.1007/s00113-008-1557-y [doi] PST - ppublish SO - Unfallchirurg. 2009 Dec;112(12):1029-33. doi: 10.1007/s00113-008-1557-y.